March 16, 2021
AstraZeneca and Daiichi Sankyo said on March 12 that they will discontinue their copromotion arrangement for the acid reducer Nexium (esomeprazole) in Japan on September 14, with the UK firm to be solely responsible for its promotion, marketing, and distribution...read more